You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Claims for Patent: 11,045,474

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,045,474

Title:	Antiviral JAK inhibitors useful in treating or preventing coronaviridae infections
Abstract:	Compounds, compositions, and methods of treatment and prevention of HIV infection are disclosed. The compounds are pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidine JAK inhibitors. Combinations of these JAK inhibitors and additional antiretroviral compounds, such as NRTI, NNRTI, integrase inhibitors, entry inhibitors, protease inhibitors, and the like, are also disclosed. In one embodiment, the combinations include a combination of adenine, cytosine, thymidine, and guanine nucleoside antiviral agents, optionally in further combination with at least one additional antiviral agent that works via a different mechanism than a nucleoside analog. This combination has the potential to eliminate the presence of HIV in an infected patient.
Inventor(s):	Gavegnano; Christina (Decatur, GA), Schinazi; Raymond F. (Miami, FL)
Assignee:	Emory University (Atlanta, GA) The United States Government as Repersentative by the Department of Veterans Affairs (Washington, DC)
Application Number:	16/816,901
Patent Claims:	1. A method of treating a Coronaviridae infection, comprising administering an effective, antiviral amount of a compound selected from the group consisting of Jakafi, and LY3009104/INCB28050 to a patient in need of treatment thereof. 2. The method of claim 1, wherein the compound is LY3009104/INCB28050. 3. A method of treating a Coronaviridae infection, comprising administering an effective, antiviral amount of Tofacitinib to a patient in need of treatment thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.